Aeterna Zentaris Completes Patient Recruitment for Confirmatory Phase 3 Trial of Macrilen

CHARLESTON, S.C.--(BUSINESS WIRE) October 26, 2016 --Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”) today announced it has successfully completed patient recruitment for the confirmatory Phase 3 clinical trial of Macrilen...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news